Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 305

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 1
Chunk 305
---
 Operating and Financial Review and Prospects” sections of this annual report above.

D. Trend Information.

Other than as described elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably likely to have a material adverse effect on our revenue, income, profitability, liquidity or capital resources, or that would cause our reported financial information not necessarily to be indicative of future operation results or financial condition.

E. Critical Accounting Estimates.

For information on our critical accounting estimates, please see “ Operating Results - Critical Accounting Policies and Significant Judgments and Estimates” section of this annual report above.

Table of Contents

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

A. Directors and Senior Management.

Business Experience and Qualifications of our Directors and Senior Management

Below is a list of the names and ages of our directors and officers as of March 19, 2025, and a brief account of the business experience of each of them. The business address for our directors and officers is c/o HUTCHMED (China) Limited, Level 18, The Metropolis Tower, 10 Metropolis Drive, Hunghom, Kowloon, Hong Kong.

  Name                             Age      Position                                                                  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Dan ELDAR                         71      Non-executive Director and Chairman                                       
  Weiguo SU                         67      Executive Director, Chief Executive Officer and Chief Scientific Officer  
  CHENG Chig Fung, Johnny           58      Executive Director and Chief Financial Officer                            
  Edith SHIH                        73      Non-executive Director and Company Secretary                              
  Ling YANG                         45      Non-executive Director                                                    
  Paul Rutherford CARTER            64      Senior Independent Non-executive Director                                 
  Renu BHATIA                       66      Independent Non-executive Director                                        
  Chaohong HU                       59      Independent Non-executive Director                                        
  Graeme Allan JACK                 74      Independent Non-executive Director                                        
  MOK Shu Kam, Tony                 64      Independent Non-executive Director                                        
  WONG Tak Wai                      68      Independent Non-executive Director                                        
  Michael Ming SHI                  59      Executive Vice President, Head of R& D and Chief Medical Officer          
  Zhenping WU                       65      Executive Vice President, Pharmaceutical Sciences and Manufacturing       
  May Qingmei WANG